Thelansis

Congenital Ichthyosis Market Outlook Thelansis’s “Congenital Ichthyosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Congenital Ichthyosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Key business questions answered: How can drug development and lifecycle management strategies be optimized across G8 markets (US, EU5, Japan, and China)? How large is the patient population in terms of incidence, prevalence, segments, and those receiving drug treatments? What is the 10-year market outlook for sales and patient share? Which events will have the greatest impact on the market’s trajectory? ...

Congenital Ichthyosis Market Outlook Thelansis’s “Congenital Ichthyosis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Congenital Ichthyosis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Congenital Ichthyosis Overview Congenital recessive ichthyoses are a heterogeneous group of disorders characterized clinically by scaling of the skin and histologically by the presence of a thickened stratum corneum. Most mutations are found in the TGM1 gene encoding transglutaminase 1, involved in forming the epidermal cornified cell envelope. ABCA12 encodes an ATP-binding cassette (ABC) transporter, involved in lipid transport, and ALOX12...

  Congenital recessive ichthyoses manifest as a diverse set of disorders marked by skin scaling and a thickened stratum corneum. Clinically, they present with symptoms such as red, dry, and rough skin, often adorned with large or fine white scales. Variability exists in scale appearance, ranging from delicate white to dark brown with deep cracks. The palms and soles may exhibit excessive thickening of the skin. These manifestations are mutations in genes like TGM1, which encodes transglutaminase 1, pivotal in forming the epidermal cornified cell envelope. Additionally, ABCA12, ALOX12B, ALOXE3, and CYP4F22 genes play lipid metabolism and transport roles. Complications can arise from severe cases, including skin dryness, tightness, and inelasticity, leading to cracking and fissures, particularly problematic in movement and daily tasks. Treatment of ichthyosis primarily focuses on hydration, lubrication, and keratolysis, achievable through topical agents or systemic retinoids for ke...